Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...

The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.

Ahead of Little Big Town's Nashville Christmas residency, the chart-topping country artist opens up about her mother's ...

Research on Parkinson’s is revealing several risk factors related to our lifestyles and environment, and you can act on some ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

Gibson's most famous moment came 37 years ago this month. Now he's leading another team towards a very different goal.

A woman living with Parkinson’s disease played her clarinet while undergoing brain stimulation, offering surgeons immediate, ...

Parkinson’s is the fastest-growing neurodegenerative condition in the world, and the Coachella Valley is uniquely affected ...

An acclaimed researcher is an expert at explaining complicated problems. Now she has to confront the most vexing question: What is happening to her?

Transcutaneous afferent patterned stimulation is linked to metabolic activity changes in the cerebellum and other brain areas ...

On a grey October morning in Exeter, 35-year-old personal trainer Tom Burridge laced up his trainers, pulled on a comically ...